IRadimed Corporation (IRMD)

US — Healthcare Sector
Peers: LUNG  OFIX  NPCE  ITGR  GKOS  HSKA  CNMD  OSA  LIVN  ELMD  KIDS  SRDX  SGHT  ANIK 

Automate Your Wheel Strategy on IRMD

With Tiblio's Option Bot, you can configure your own wheel strategy including IRMD - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol IRMD
  • Rev/Share 5.9111
  • Book/Share 7.083
  • PB 8.2084
  • Debt/Equity 0.0007
  • CurrentRatio 8.8673
  • ROIC 0.1922

 

  • MktCap 739255914.0
  • FreeCF/Share 1.101
  • PFCF 52.8117
  • PE 37.362
  • Debt/Assets 0.0006
  • DivYield 0.011
  • ROE 0.2328

 

  • Rating A-
  • Score 4
  • Recommendation Buy
  • P/E Score 1
  • DCF Score 4
  • P/B Score 1
  • D/E Score 4

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

IRADIMED CORPORATION (IRMD) Q1 2025 Earnings Call Transcript
IRMD
Published: May 05, 2025 by: Seeking Alpha
Sentiment: Neutral

IRADIMED CORPORATION (NASDAQ:IRMD ) Q1 2025 Earnings Conference Call May 5, 2025 9:00 AM ET Company Participants Roger Susi - Founder, President & CEO John Glenn - CFO Conference Call Participants Frank Takkinen - Lake Street Capital Markets Operator Welcome to the IRADIMED Corporation First Quarter of 2025 Financial Results Conference Call. Currently, all participants are in a listen-only mode.

Read More
image for news IRADIMED CORPORATION (IRMD) Q1 2025 Earnings Call Transcript
IRadimed (IRMD) Lags Q1 Earnings Estimates
IRMD
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Negative

IRadimed (IRMD) came out with quarterly earnings of $0.42 per share, missing the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.36 per share a year ago.

Read More
image for news IRadimed (IRMD) Lags Q1 Earnings Estimates
CORRECTION -- IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025
IRMD
Published: April 28, 2025 by: GlobeNewsWire
Sentiment: Neutral

WINTER SPRINGS, Fla., April 28, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by IRADIMED CORPORATION (NASDAQ: IRMD), please note that in the first paragraph the date of the earnings call should read "Monday, May 5, 2025" instead of "Friday, May 5, 2025". The corrected release follows:

Read More
image for news CORRECTION -- IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025
IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025
IRMD
Published: April 28, 2025 by: GlobeNewsWire
Sentiment: Neutral

WINTER SPRINGS, Fla., April 28, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 first quarter financial results before the market opens on Friday, May 5, 2025. Iradimed management will host a conference call the same day beginning at 9:00 a.m. Eastern Time to discuss those results and to answer questions.

Read More
image for news IRADIMED CORPORATION to Hold First Quarter of 2025 Financial Results Conference Call on May 5, 2025
IRadimed Corporation: Steady, Low-Risk Grower In The Devices Space
IRMD
Published: April 08, 2025 by: Seeking Alpha
Sentiment: Positive

IRadimed Corporation offers steady revenue growth with 14 consecutive quarters of record revenue and a small dividend, despite recent stock price decline. IRMD's unique MRI-compatible IV infusion pump and patient monitoring system face limited competition, ensuring a strong market position. Financials show robust performance with a 21% increase in US sales, but international sales dipped possibly due to cheaper alternatives in Asian markets.

Read More
image for news IRadimed Corporation: Steady, Low-Risk Grower In The Devices Space

About IRadimed Corporation (IRMD)

  • IPO Date 2014-07-16
  • Website https://www.iradimed.com
  • Industry Medical - Devices
  • CEO Mr. Roger E. Susi
  • Employees 160

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.